Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Schizophr Res. 2015 Nov 14;169(0):374–380. doi: 10.1016/j.schres.2015.10.042

Figure 2.

Figure 2

A. The density of OLIG2-immunoreactive cells is significantly decreased whereas the density of NG2-immunoreactive cells is unaltered in subjects with schizophrenia. B. Photomicrographs showing OLIG2-immunoreactive cells in a schizophrenia (right) and a normal control (left) subjects. Scale bar=50 μm.